🔎 Trials Near Me

Akèy › Kansè ovè › Kalifòni › Baldwin Park

Etid klinik pou Kansè ovè nan Baldwin Park, CA

25 etid pou Kansè ovè ap chèche patisipan nan sit nan ak bò kote Baldwin Park (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors

Ap rekriteFaz 1/2
  • Research Site, Duarte · 4 mi lwen
Laj 18 a 130 · Tout sèks · Mizajou Oct 5, 2026 · NCT05797168

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

Ap rekriteFaz 1
  • City of Hope National Medical Center, Duarte · 4 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06465069

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Ap rekriteFaz 2
  • City of Hope, Duarte · 4 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06172478

A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian Cancer

Ap rekriteFaz 1
  • City of Hope National Medical Center /ID# 281381, Duarte · 4 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07278336

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

Ap rekriteFaz 1
  • Research Site, Duarte · 4 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT05877599

A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab

Ap rekriteFaz 1/2
  • City of Hope Comprehensive Cancer Center, Duarte · 4 mi lwen
Laj 18 ak plis · Fanm · Mizajou Sep 24, 2026 · NCT04590326

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

Ap rekriteFaz 3
  • City of Hope, Duarte, Duarte · 4 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07213804

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

Ap rekriteFaz 1
  • City of Hope Cancer Center, Duarte · 4 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT05983432

BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)

Ap rekriteFaz 1/2
  • City of Hope National Medical Center, Duarte · 4 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT04752826

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

Ap rekriteFaz 1/2
  • City of Hope, Duarte · 4 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT07109726

Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

Ap rekriteFaz 3
  • City of Hope Medical Center, Duarte · 4 mi lwen
Laj 18 ak plis · Fanm · Mizajou Sep 15, 2026 · NCT07214779

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

Ap rekriteFaz 1
  • City of Hope, Duarte · 4 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT06293898

PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer

Ap rekriteFaz 1
  • City of Hope Medical Center, Duarte · 4 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Aug 26, 2026 · NCT04329494

Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors

Ap rekriteFaz 1
  • City of Hope, Duarte · 4 mi lwen
Laj 15 ak plis · Tout sèks · Mizajou Aug 25, 2026 · NCT06276491

A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer

Ap rekrite
  • City of Hope Medical Center, Duarte · 4 mi lwen
Laj 18 ak plis · Fanm · Mizajou Aug 10, 2026 · NCT07741968

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

Ap rekrite
  • City of Hope Comprehensive Cancer Center, Duarte · 4 mi lwen
Laj 35 a 50 · Fanm · Mizajou Aug 7, 2026 · NCT04251052

AOH1996 for the Treatment of Refractory Solid Tumors

Ap rekriteFaz 1
  • City of Hope Medical Center, Duarte · 4 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Jul 28, 2026 · NCT05227326

Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

Ap rekrite
  • Beckman Research Institute of City of Hope, Duarte · 4 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Apr 30, 2026 · NCT05297734

Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer

Ap rekriteFaz 3
  • City of Hope, Duarte · 4 mi lwen
Laj 18 ak plis · Fanm · Mizajou Apr 16, 2026 · NCT05659381

Safety and Immunogenicity of Innocell Autologous Cellular Immunotherapy for Recurrent Epithelial Ovarian Cancer

Ap rekriteFaz 1
  • City of Hope, Duarte · 4 mi lwen
Laj 18 ak plis · Fanm · Mizajou Mar 27, 2026 · NCT06366490

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • City of Hope, Duarte · 4 mi lwen
Laj 40 ak plis · Tout sèks · Mizajou Jan 20, 2026 · NCT05366881

CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.

Ap rekriteFaz 2
  • City of Hope National Medical Center, Duarte · 4 mi lwen
Laj 18 ak plis · Fanm · Mizajou Dec 23, 2025 · NCT06690775

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Ap rekriteEtid obsèvasyon
  • Massive Bio SYNERGY-AI site, Duarte · 4 mi lwen
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

Etid Kansè ovè nan lòt vil

Lòt etid nan Baldwin Park

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.